908112-43-6 Usage
Uses
Different sources of media describe the Uses of 908112-43-6 differently. You can refer to the following data:
1. SNX-2112 is a selective heat shock protein 90 (Hsp90) inhibitor which can exert a potent anticancer activity. Studies demonstates that SNX-2112 can exhibit a potent anticancer activity against B16 mel
anoma cells both in vitro and in vivo, by inhibiting cell proliferation and inducing cell cycle arrest and apoptosis in a mechanism dependent on the degredation of Hsp90 client proteins.
2. SNX-2112 is a selective heat shock protein 90 (Hsp90) inhibitor which can exert a potent anticancer activity. Studies demonstates that SNX-2112 can exhibit a potent anticancer activity against B16 melanoma cells both in vitro and in vivo, by inhibiting cell proliferation and inducing cell cycle arrest and apoptosis in a mechanism dependent on the degredation of Hsp90 client proteins.
Check Digit Verification of cas no
The CAS Registry Mumber 908112-43-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,8,1,1 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 908112-43:
(8*9)+(7*0)+(6*8)+(5*1)+(4*1)+(3*2)+(2*4)+(1*3)=146
146 % 10 = 6
So 908112-43-6 is a valid CAS Registry Number.
908112-43-6Relevant articles and documents
COMBINATION THERAPY FOR TREATING CANCER
-
Page/Page column 63; 74; 75, (2019/02/02)
A method of treating cancer comprising administering an effective amount of each of a chemotherapeutic agent and an Hsp90 inhibitor, either separately or as a covalent conjugate of the two, to provide a combination therapy having an enhanced therapeutic e
